Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
Today: 27/07/2026 · FUTURE · Forthcoming · Viewed
Funding agency: Horizon Europe
Call: HORIZON-HLTH-2027-01
Type of action: HORIZON-RIA HORIZON Research and Innovation Actions | Deadline model: single-stage | Planned opening: 10/02/2027 | Model Grant Agreement: HORIZON Action Grant Budget-Based
The call aims to develop novel small molecule antiviral therapeutics for pathogens with epidemic potential. The programme period is 2021-2027, and the topic focuses on tackling diseases and reducing disease burden.
Budget total: — EUR | Budget per project: — EUR
Deadline: 13/04/2027 (260 days left) | Duration: — months | Funding intensity: —% | Type: research
Eligibility: entity types: legal entity established in the United States of America; countries: EU member states, associated countries
#health#disease#antiviral therapeutics#epidemic potential
HealthEducation & Training
Matching by organization
"Rule filter" means the score came from a hard eligibility/preference check, not the AI — if that reasoning looks wrong for a specific organization, use Override below to correct it by hand; the system's own score stays visible for comparison and is never silently replaced.
| Organization | Match % | Source | Rationale | Override |
|---|---|---|---|---|
| European Centre for Emerging Competencies and Technologies | 70% | ollama |
The opportunity's focus on 'Health' domain and developing antiviral therapeutics…The opportunity's focus on 'Health' domain and developing antiviral therapeutics aligns with the organization's mission to foster emerging skills in STEM and environmental sustainability, particularly in areas like biotechnology which is related to their 'AgriTech Solutions' domain. However, there is no clear overlap with the organization's expertise in robotics, digital transformation, or entrepreneurship. |
Override |
| Novatex Solutions LTD | 35% | ollama |
The organization's profile does not match the opportunity's topic, which is focu…The organization's profile does not match the opportunity's topic, which is focused on health and antiviral therapeutics. The only domain overlap is 'Education & Training', but this is a weak connection. The technologies do not align at all, with 'AI and Big Data' and 'Robotics' being unrelated to the call's focus. [Weighted score: 0% AI judgment (65%) + 100% domain/technology tag overlap (35%) = 35%] |
Override |